Table 8.
Outcome | Study | Vaccine | % Vaccine | % Control | Relative risk (95% CI) |
---|---|---|---|---|---|
SAE | |||||
FUTURE I | Gardasil® | 1.8 | 1.7 | 1.07 (0.71–1.60) | |
FUTURE II | Gardasil® | 0.7 | 0.9 | 0.83 (0.56–1.24) | |
PATRICIA | Cervarix® | 7.5 | 7.5 | 1.00 (0.91–1.11) | |
Injection-related SAE | |||||
FUTURE I | Gardasil® | 0.03 | 0.0 | 3.00 (0.12–73.58) | |
FUTURE I | Gardasil® | 0.05 | 0.03 | 1.50 (0.25–8.99) | |
PATRICA | Cervarix® | 0.12 | 0.06 | 1.83 (0.68–4.96) |
CI: Confidence interval; SAE: serious adverse event. Data from reference [38].